Rocaltrol / 羅鈣全 - Hong Kong[香港药品]

TOP

Rocaltrol / 羅鈣全

2014-05-19 14:27:20 来源: 作者: 【大中小】浏览:681次评论:0条

See related Rocaltrol cap information

Manufacturer

Roche

Distributor

Hong Kong: DKSH

Contents

Calcitriol

Indications

Postmenopausal osteoporosis, renal osteodystrophy in patients w/ chronic renal failure, particularly those undergoing haemodialysis. Postsurgical hypoparathyroidism. Idiopathic hypoparathyroidism. Pseudohypoparathyroidism. Vit D-dependent rickets. Hypophosphataemic vit D-resistant rickets.
Click to view Rocaltrol detailed prescribing infomation

Dosage

Established postmenopausal osteoporosis 0.25 mcg bd, may be increased at mthly intervals to max: 0.5 mcg bd. Renal osteodystrophy 0.25 mcg/day, may be increased by 0.25 mcg/day at 2-4 wk intervals. Hypoparathyroidism & rickets 0.25 mcg/day, may be increased at 2-4 wk intervals.
Click to view Rocaltrol detailed prescribing infomation

Overdosage

View Rocaltrol overdosage for action to be taken in the event of an overdose.

Administration

May be taken with or without food (May be taken w/ meals to reduce GI discomfort.).

Contraindications

Hypercalcemia, vit D intoxication.
Click to view Rocaltrol detailed prescribing infomation

Warnings

For additional cautionary notes to warn of the potential risk of using the medicine... click to view Rocaltrol detailed prescribing infomation

Special Precautions

Infants. Pregnancy & lactation.
Click to view Rocaltrol detailed prescribing infomation

Adverse Drug Reactions

Hypercalcemia syndrome, Ca intoxication.
View ADR Monitoring Form

Side Effects

View Rocaltrol side effects

Drug Interactions

Mg-containing drugs. Phosphate-binding agents (adjust dosage). Cholestyramine.
View more drug interactions with Rocaltrol

Pregnancy Category (US FDA)

Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.



if dose > US RDA.

Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective).

Storage

View Rocaltrol storage conditions for details to ensure optimal shelf-life.

Description

View Rocaltrol description for details of the chemical structure and excipients (inactive components).

Mechanism of Action

View Rocaltrol mechanism of action for pharmacodynamics and pharmacokinetics details.

ATC Classification

A11CC04 - calcitriol ; Belongs to the class of vitamin D and analogues. Used as dietary supplements.

Presentation/Packing

Form

Packing

Photo